Health Food Certificate
敏自寧L. j EM
|Ministry of Health and Welfare Food No. A00141|
Improving Allergic Body Conditions
舒敏佳Comprobi®L. r MP108
|Ministry of Health and Welfare Food No. A00271|
Improving Allergic Body ConditionsValidated by animal trials:
1. Effective in reducing allergy related IgE antibody production.
2. Effective in relieving respiratory tract hypersensitivity.
3. Aid in the regulation of Th1/Th2cytokine.
天天佳An-Ti AllergyL. paracasei
|Ministry of Health and Welfare Food No. A00232|
1.Effective in promoting IgG production.
2.Effective in regulating T cell cytokine.
Assist in Improving Allergic Body Conditions
1.Effective in reducing allergic response IgE secretion.
2.Effective in promoting immuno IFN-r cells secretion in lungs.
Clinical human trials
|Research purpose||Collaboration||Research topic|
|L. j EM||Chung Shan Medical University Hospital||A randomized open trial for comparing Xyzal and Xyzal with Lactobacillus johnsonii EM in the treatment clinically chronic allergic rhinitis for children age 7 to 12.|
|L. r MP108||Chung Shan Medical University Hospital||Assess the adjuvant therapy effectiveness and efficiency of Lactobacillus rhamnosusfor treating chronic allergic rhinitis in children. The study was an 8 weeks, double blinded, placebo controlled, and 4 weeks followed-up research.|
|L. r MP108||Chung Shan Medical University Hospital, Taipei City Hospital Renai Branch||Assess the adjuvant therapy effectiveness and efficiency of Lactobacillus rhamnosusfor treating atopic dermatitis in children of age 4 month to 4 years. The study was an 8 weeks, randomized, double blinded, and placebo controlled research.|
|L. p||Taichung veterans general hospital||Assess the adjuvant therapy effectiveness and efficiency of Lactobacillus paracaseifor treating chronic allergic rhinitis in children of age 6 to 13 years. The study was a 12 weeks, double blinded, and placebo controlled research.|
International journal publication
|Int J Pediatr Otorhinolaryngol. 2012 Jul;76(7):994-1001.||A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12 years.||The 24-week, 2-phase, crossover treatment program showed that levocetirizine plus L.j EM1 was more effective for PAR than levocetirizine and that this difference persisted for at least 3 months after discontinuation of L.j EM1.|
|Pediatr Neonatol. 2014 Jun;55(3):181-8||Evaluation of the effect of Lactobacillus paracasei (HF.A00232) in children (6-13 years old) with perennial allergic rhinitis: a 12-week, double-blind, randomized, placebo-controlled study.||Pediatr Neonatol. 2014 Jun;55(3):181-8 Evaluation of the effect of Lactobacillus paracasei (HF.A00232) in children (6-13 years old) with perennial allergic rhinitis: a 12-week, double-blind, randomized, placebo-controlled study.Dietary supplementation with LP (HF.A00232) provided no additional benefit when used with regular levocetirizine in treating AR in the initial 8 weeks of our study, but there was a continuing decrease in PRQLQ scores, as well as a significant improvement in individual symptoms of sneezing, itchy nose, and swollen eyes, after discontinuing regular levocetirizine treatment.|